The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

respirogen.com

Founded Year

2017

Stage

Debt - II | Alive

Total Raised

$770K

Last Raised

$250K | 3 yrs ago

About Respirogen

Respirogen commercializing technology developed at Columbia University and The University of Colorado, providing improved compositions for blood oxygenation and improved methods for producing and delivering these oxygen delivery compositions to patients or explanted cells, tissues, or organs.

Respirogen Headquarter Location

5757 Central Avenue Suite B

Boulder, Colorado, 80301,

United States

303-906-1100

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Respirogen

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Respirogen is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Respirogen Patents

Respirogen has filed 6 patents.

The 3 most popular patent topics include:

  • Industrial gases
  • Medical equipment
  • Causes of death
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/9/2020

Pharmacokinetics, Prodrugs, Analgesics, Biotechnology, Medical equipment

Application

Application Date

11/9/2020

Grant Date

Title

Related Topics

Pharmacokinetics, Prodrugs, Analgesics, Biotechnology, Medical equipment

Status

Application

  • When was Respirogen founded?

    Respirogen was founded in 2017.

  • Where is Respirogen's headquarters?

    Respirogen's headquarters is located at 5757 Central Avenue, Boulder.

  • What is Respirogen's latest funding round?

    Respirogen's latest funding round is Debt - II.

  • How much did Respirogen raise?

    Respirogen raised a total of $770K.

  • Who are the investors of Respirogen?

    Investors of Respirogen include Innosphere, University of Colorado and Columbia University.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.